[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100513739":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":20,"locations":21,"responsibleParty":55,"collaborators":20,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":20,"studyType":71,"phases":72,"briefSummary":75,"conditions":76,"keywords":20,"overallStatus":79,"whyStopped":20,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Gelscom SAS","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Intradiscal Gelified Ethanol Arm","EXPERIMENTAL","Patients who come with symptomatic cervical disc herniation or with cervical discogenic pain and meet the eligibility criteria.",[13],"Device: Intradiscal Gelified Ethanol (Discogel)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Intradiscal Gelified Ethanol (Discogel)","Intradiscal percutaneous injection of an intradiscal Gelified Ethanol",[9],null,[22,39],{"facility":23,"status":20,"city":24,"state":20,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Santissima Trinità Hospital Ascagliari","Cagliari","9121","Italy","IT",{"type":29,"coordinates":30},"Point",[31,32],9.11917,39.23054,{"lat":32,"lon":31},[35],{"name":36,"role":37,"phone":20,"phoneExt":20,"email":38},"Stefano Marcia, Pr","CONTACT","stemarcia@gmail.com",{"facility":40,"status":20,"city":41,"state":20,"zip":42,"country":26,"countryCode":27,"cosmosGeoPoint":43,"geoPoint":47,"contacts":48},"Azienda Ospedaliera Universitaria","Siena","53000",{"type":29,"coordinates":44},[45,46],11.33064,43.31822,{"lat":46,"lon":45},[49,52],{"name":50,"role":37,"phone":20,"phoneExt":20,"email":51},"Matteo Bellini, Dr","matteo.bellini@icloud.com",{"name":53,"role":37,"phone":20,"phoneExt":20,"email":54},"Chiara Zini","zini.chiara@gmail.com",{"type":56,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100513739","phase-2-evaluation-of-efficacy-and-safety-of-intradiscal-gelified-ethanol-in-refractory-cervical-discogenic-pain-100513739",false,"NCT05969392","Evaluation of Efficacy and Safety of Intradiscal Gelified Ethanol in Refractory Cervical Discogenic Pain","Intradiscal Gelified Ethanol in Refractory Cervical Discogenic Pain : a Interventional, Prospective, Multi-center, Open-label Study.","DISCOCERV","Inclusion Criteria:\n\n* Patient 18 years or older;\n* Pain refractory to conservative treatments for more than 2 months, non-surgical patients\n* Cervicobrachialgia due to disc herniation\n* Chronic discogenic pain (1 or 2 cervical discs) with concordant MRI;\n* Patient agreeing to participate in the study and having given written consent;\n* Patient enrolled in a health insurance plan.\n\nExclusion Criteria:\n\n* Prior surgical treatment of the disc(s) studied;\n* Sick leave of more than 12 months secondary to painful symptoms;\n* Patient with Modic 1 score or more\n* History of cognitive-behavioral disorders that could affect the completion of self-questionnaires;\n* Local or systemic infection, or suspicion of infection;\n* Severe coagulation disorders;\n* Other inflammatory rheumatic disease;\n* Severe underlying pathology with life expectancy \\\u003C1 year;\n* Women of childbearing age who are pregnant at the inclusion visit or who wish to become pregnant before the administration of the treatment (V0);\n* Known allergy to contrast material and\u002For local anesthetic substances;\n* Patients who cannot read or write Italian;\n* Major person benefiting from a legal protection regime (guardianship, curatorship, safeguard of justice);","ALL","18 Years","120 Years",{"count":69,"type":70},60,"ESTIMATED","INTERVENTIONAL",[73,74],"PHASE2","PHASE3","The purpose of this study is to assesse safety and efficacy of the Intradiscal Gelified Ethanol for treatment in refractory cervical discogenic pain.",[77,78],"Pain, Cervical","Discogenic Pain","NOT_YET_RECRUITING","2025-03-07",{"date":82,"type":83},"2025-03-11","ACTUAL",{"date":85,"type":70},"2025-04",{"date":87,"type":70},"2026-04",{"name":5,"class":6},2]